148 related articles for article (PubMed ID: 29374492)
1. Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning.
Olesen AE; Grønlund D; Gram M; Skorpen F; Drewes AM; Klepstad P
BMC Res Notes; 2018 Jan; 11(1):78. PubMed ID: 29374492
[TBL] [Abstract][Full Text] [Related]
2. Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?
Chatti I; Creveaux I; Woillard JB; Langlais S; Amara A; Ben Fatma L; Saad A; Gribaa M; Libert F
Therapie; 2016 Oct; 71(5):507-513. PubMed ID: 27288213
[TBL] [Abstract][Full Text] [Related]
3. Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review.
Lucenteforte E; Vannacci A; Crescioli G; Lombardi N; Vagnoli L; Giunti L; Cetica V; Coniglio ML; Pugi A; Bonaiuti R; Aricò M; Giglio S; Messeri A; Barale R; Giovannelli L; Mugelli A; Maggini V
BMC Cancer; 2019 Jan; 19(1):113. PubMed ID: 30704436
[TBL] [Abstract][Full Text] [Related]
4. Pain polymorphisms and opioids: An evidence based review.
Vieira CMP; Fragoso RM; Pereira D; Medeiros R
Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
[TBL] [Abstract][Full Text] [Related]
5. [Genetic polymorphisms and human sensitivity to pain and opioids].
Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
[TBL] [Abstract][Full Text] [Related]
6. Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Terashima M; Yoshida T; Sakai K; Otake Y; Koyama A; Nishio K; Nakagawa K
BMC Cancer; 2017 Oct; 17(1):674. PubMed ID: 28985716
[TBL] [Abstract][Full Text] [Related]
7. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
[TBL] [Abstract][Full Text] [Related]
8. Human Genetic Variability Contributes to Postoperative Morphine Consumption.
De Gregori M; Diatchenko L; Ingelmo PM; Napolioni V; Klepstad P; Belfer I; Molinaro V; Garbin G; Ranzani GN; Alberio G; Normanno M; Lovisari F; Somaini M; Govoni S; Mura E; Bugada D; Niebel T; Zorzetto M; De Gregori S; Molinaro M; Fanelli G; Allegri M
J Pain; 2016 May; 17(5):628-36. PubMed ID: 26902643
[TBL] [Abstract][Full Text] [Related]
9. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
Reyes-Gibby CC; Shete S; Rakvåg T; Bhat SV; Skorpen F; Bruera E; Kaasa S; Klepstad P
Pain; 2007 Jul; 130(1-2):25-30. PubMed ID: 17156920
[TBL] [Abstract][Full Text] [Related]
10. Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
Aubrun F; Zahr N; Langeron O; Boccheciampe N; Cozic N; Belin L; Hulot JS; Khiami F; Riou B
Eur J Anaesthesiol; 2018 Jul; 35(7):496-504. PubMed ID: 29474345
[TBL] [Abstract][Full Text] [Related]
11. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
12. Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects.
Kolesnikov Y; Gabovits B; Levin A; Voiko E; Veske A
Anesth Analg; 2011 Feb; 112(2):448-53. PubMed ID: 21127283
[TBL] [Abstract][Full Text] [Related]
13. Evidence Regarding Pharmacogenetics in Pain Management and Cancer.
Smith DM; Figg WD
Oncologist; 2023 Mar; 28(3):189-192. PubMed ID: 36718020
[TBL] [Abstract][Full Text] [Related]
14. Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Sakai K; Yoshida T; Nakura M; Sakamoto R; Makimura C; Ohtake Y; Tanaka K; Hayashi H; Takeda M; Okuno T; Takegawa N; Haratani K; Koyama A; Nishio K; Nakagawa K
Oncologist; 2023 Mar; 28(3):278-e166. PubMed ID: 36426809
[TBL] [Abstract][Full Text] [Related]
15. Single-Nucleotide Polymorphisms in TAOK3 Are Associated With High Opioid Requirement for Pain Management in Patients With Advanced Cancer Admitted to a Tertiary Palliative Care Unit.
Gutteridge T; Kumaran M; Ghosh S; Fainsinger R; Klepstad P; Tarumi Y; Damaraju S; Baracos VE
J Pain Symptom Manage; 2018 Oct; 56(4):560-566. PubMed ID: 30031856
[TBL] [Abstract][Full Text] [Related]
16. OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients.
Viet CT; Dang D; Aouizerat BE; Miaskowski C; Ye Y; Viet DT; Ono K; Schmidt BL
J Pain; 2017 Sep; 18(9):1046-1059. PubMed ID: 28456745
[TBL] [Abstract][Full Text] [Related]
17. Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirement.
Matic M; Jongen JL; Elens L; de Wildt SN; Tibboel D; Sillevis Smitt PA; van Schaik RH
Pharmacogenomics; 2017 Aug; 18(12):1133-1142. PubMed ID: 28745577
[TBL] [Abstract][Full Text] [Related]
18. Acute pain Factors predictive of post-operative pain and opioid requirement in multimodal analgesia following knee replacement.
Thomazeau J; Rouquette A; Martinez V; Rabuel C; Prince N; Laplanche JL; Nizard R; Bergmann JF; Perrot S; Lloret-Linares C
Eur J Pain; 2016 May; 20(5):822-32. PubMed ID: 26517014
[TBL] [Abstract][Full Text] [Related]
19. [M1-OPIOID RECEPTOR AND CATECHOL-O-METILTRANSFERASE GENES POLYMORPHISM EFFECTS ON PERIOPERATIVE PSYCHOLOGICAL CONDITION OF THE PATIENTS AND THE EFFECTIVENESS OF POSTOPERATIVE ANALGESIA WITH OPIOIDS].
Potapov AL; Boiarkina AV
Anesteziol Reanimatol; 2015; 60(3):48-51. PubMed ID: 26415297
[TBL] [Abstract][Full Text] [Related]
20. Opioid treatment failure in cancer patients: the role of clinical and genetic factors.
Oosten AW; Matic M; van Schaik RH; Look MP; Jongen JL; Mathijssen RH; van der Rijt CC
Pharmacogenomics; 2016 Aug; 17(13):1391-403. PubMed ID: 27472837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
